Top Markets
Coin of the day
Johnson & Johnson Johnson & Johnson

Johnson & Johnson

JNJ
Helyezés a részvények között #18
Johnson & Johnson, together with its subsidiaries, researches and develops,... Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the AVEENO, CLEAN & CLEAR, DR. CI:LABO, NEUTROGENA, and OGX brands; TYLENOL acetaminophen products; SUDAFED cold, flu, and allergy products; BENADRYL and ZYRTEC allergy products; MOTRIN IB ibuprofen products; NICORETTE smoking cessation products; and PEPCID acid reflux products. It also offers STAYFREE and CAREFREE sanitary pads; o.b. tampons; adhesive bandages under the BAND-AID brand; and first aid products under the NEOSPORIN brand. It serves general public, retail outlets, and distributors. The company's Pharmaceutical segment offers products for rheumatoid arthritis, psoriatic arthritis, inflammatory bowel disease, and psoriasis; HIV/AIDS and COVID-19 infectious diseases; mood disorders, neurodegenerative disorders, and schizophrenia; prostate cancer, hematologic malignancies, lung cancer, and bladder cancer; thrombosis, diabetes and macular degeneration; and pulmonary arterial hypertension. This segment serves retailers, wholesalers, distributors, hospitals, and healthcare professionals directly for prescription use. Its MedTech segment provides electrophysiology products to treat cardiovascular diseases; neurovascular care products to treat hemorrhagic and ischemic stroke; orthopaedics products in support of hips, knees, trauma, spine, sports, and other; advanced and general surgery solutions that focus on breast aesthetics, ear, nose, and throat procedures; and disposable contact lenses and ophthalmic products related to cataract and laser refractive surgery under the ACUVUE brand. This segment serves wholesalers, hospitals, and retailers. The company was founded in 1886 and is based in New Brunswick, New Jersey.
Részvényárfolyam
$240.45
Piaci kapitalizáció
$579.46B
Változás (1 nap)
0.51%
Változás (1 év)
46.88%
Ország
US
Kereskedés Johnson & Johnson (JNJ)

Kategória

Bevétel a(z) Johnson & Johnson (JNJ) részvényhez
Bevétel ekkor: Dec 2025 TTM: $94.19B
Johnson & Johnson legfrissebb pénzügyi jelentései szerint a vállalat jelenlegi árbevétele (TTM) $94.19B. 2024 évben a vállalat $88.82B árbevételt ért el, amely növekedés a 2023 évben elért $85.16B árbevételhez képest. Az árbevétel az a teljes összeg, amit a vállalat termékek vagy szolgáltatások eladásából generál. A nyereséggel ellentétben ebből nem vonódnak le költségek.
Johnson & Johnson bevételtörténete 2000 és 2026 között
Bevétel az év végén
Év Bevétel Változtassa meg
2026 (TTM) $94.19B 0.00%
2025 $94.19B 6.05%
2024 $88.82B 4.30%
2023 $85.16B 8.15%
2022 $78.74B -4.65%
2021 $82.58B 0.64%
2019 $82.06B 0.59%
2018 $81.58B 6.71%
2017 $76.45B 6.34%
2016 $71.89B 2.59%
2015 $70.07B -5.73%
2014 $74.33B 4.23%
2013 $71.31B 6.08%
2012 $67.22B 3.37%
2011 $65.03B 5.59%
2010 $61.59B -0.50%
2009 $61.90B -2.90%
2008 $63.75B 4.34%
2007 $61.10B 14.57%
2006 $53.32B 5.56%
2005 $50.51B 6.69%
2004 $47.35B 13.10%
2003 $41.86B 15.33%
2002 $36.30B 12.32%
2001 $32.32B 10.78%
2000 $29.17B 0.00%
Hasonló cégek vagy versenytársak bevétele
Vállalat Bevétel Bevételkülönbség Ország
$65.18B -30.80%
US
$61.16B -35.07%
US
$56.15B -40.39%
CH
$58.74B -37.64%
GB
$65.01B -30.98%
US